KR20170141972A - Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component - Google Patents
Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component Download PDFInfo
- Publication number
- KR20170141972A KR20170141972A KR1020160075089A KR20160075089A KR20170141972A KR 20170141972 A KR20170141972 A KR 20170141972A KR 1020160075089 A KR1020160075089 A KR 1020160075089A KR 20160075089 A KR20160075089 A KR 20160075089A KR 20170141972 A KR20170141972 A KR 20170141972A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- preventing
- health functional
- functional food
- food composition
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title claims abstract description 29
- 235000020824 obesity Nutrition 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 89
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 46
- 239000000843 powder Substances 0.000 claims abstract description 28
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 210000001789 adipocyte Anatomy 0.000 claims abstract description 7
- 238000000855 fermentation Methods 0.000 claims description 63
- 230000004151 fermentation Effects 0.000 claims description 63
- 239000012141 concentrate Substances 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 19
- 235000013376 functional food Nutrition 0.000 claims description 17
- 235000021329 brown rice Nutrition 0.000 claims description 12
- 239000011449 brick Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 7
- 238000009825 accumulation Methods 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 241000589220 Acetobacter Species 0.000 claims description 2
- 239000012531 culture fluid Substances 0.000 claims 2
- 235000015140 cultured milk Nutrition 0.000 claims 2
- 235000014048 cultured milk product Nutrition 0.000 claims 1
- 206010035653 pneumoconiosis Diseases 0.000 claims 1
- 230000004069 differentiation Effects 0.000 abstract description 4
- 235000011615 Pinus koraiensis Nutrition 0.000 abstract 1
- 240000007263 Pinus koraiensis Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 23
- 235000008504 concentrate Nutrition 0.000 description 20
- 239000006227 byproduct Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 8
- 241000238557 Decapoda Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 4
- 235000011613 Pinus brutia Nutrition 0.000 description 4
- 241000018646 Pinus brutia Species 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 241000589234 Acetobacter sp. Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000252229 Carassius auratus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 238000003723 Smelting Methods 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- -1 olive oil Chemical compound 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000000786 pneumoconiotic effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 231100000507 endocrine disrupting Toxicity 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방, 개선 및 치료용 조성물에 관한 것이다.The present invention relates to a composition for preventing, ameliorating and treating obesity, which comprises a fermented product of a goldsmith carrier as an active ingredient.
비만은 에너지의 섭취와 소비의 불균형에 의해서 야기되는 현상으로 체내에 지방이 과잉 축적되어 있는 상태를 의미한다. 다양한 원인에 의해 야기되기 때문에 명확한 원인은 아직 밝혀지지 않았지만 일반적으로 지나친 열량 섭취, 내분비 장애, 운동부족, 유전적 요인 등에 기인하는 것으로 인식되고 있다. 그리고 생활 습관과 밀접한 관계가 있기 때문에 일반적으로 생활 습관병이라고도 한다. 전 세계적으로 비만 인구는 지속적으로 증가하고 있는 추세이며, 소득수준의 향상과 식생활 습관이 서구화되면서 국내 비만 인구가 급증하고 있다. 국민건강통계 자료에 따르면 만 19세 이상의 비만 유병률은 1998년 26.0%에서 지속적으로 증가하여 2008년에는 31.0%로, 이는 미국(만 20세 이상, 체질량지수 30kg/m2 이상)의 비만유병률 32.2%와 비슷한 수준으로 나타났다. 비만이 심각한 사회적 문제로 대두하면서 국내에서도 성인병의 주요원인으로 자리 잡고 있는 비만을 예방하기 위해 다양한 대책과 활발한 연구가 진행되고 있다. 비만 치유를 위한 방법으로는 식사 등 생활 습관의 개선과 약물투여, 수술 등이 있으며, 최근에는 건강기능식품 시장이 커지면서 식이 조절과 병행한 기능성 식품으로 개선하려는 시도가 많이 이루어지고 있으며, 건강기능성 식품에 관한 법률이 제정되어 다양한 건강기능성 소재 및 식품이 식품의약품안전청의 허가를 받아 유통되고 있다. 이와 같이 다양한 방법으로 비만을 예방, 개선 또는 치료하고자 노력하고 있으나 여전히 비만 인구는 증가하고 있는 실정이다. Obesity is a phenomenon caused by an imbalance in consumption and consumption of energy, which means that the body is over-accumulated. Although it is not clear yet why the cause is caused by various causes, it is generally recognized that it is caused by excessive calorie intake, endocrine disruption, lack of exercise, genetic factors, and the like. It is also commonly referred to as lifestyle-related diseases because it is closely related to lifestyle habits. The worldwide obesity population is steadily increasing. As the income level and eating habits are westernized, the number of obese people in Korea is increasing rapidly. According to the national health statistics, the prevalence of obesity over 19 years of age continuously increased from 26.0% in 1998 to 31.0% in 2008, which is 32.2% in the United States (over 20 years old, body mass index 30kg / Similar level. Obesity has become a serious social problem, and various measures and active researches are under way in Korea to prevent obesity, which is a major cause of adult diseases. As a method for healing obesity, there are improvement of lifestyle such as eating, drug administration, and surgery. Recently, as the market for health functional foods has increased, many attempts have been made to improve functional foods in parallel with dietary control. Has been enacted, and a variety of health functional materials and foods have been licensed by the Korea Food and Drug Administration. Although many efforts have been made to prevent, ameliorate, or treat obesity, obesity is still increasing.
한편, 소나무와 솔잎은 예로부터 항균, 살균 및 탈취작용이 있는 것으로 알려져 있고, 특히 춘양목이라고도 불리는 금강송은 독특한 나무 구조 때문에 뛰어난 탈취작용이 있다고 알려져 있다. 솔잎을 유효성분으로 포함하는 관련 기술의 일례로, 한국공개특허 제2014-0036053호에 솔잎 착즙액을 유효성분으로 함유하는 대사 증후군 개선 기능성 떡에 대한 기술이 개시되어 있고, 한국등록특허 제1326271호에 항 비만 효과를 가지는 진피발효 추출물의 제조방법과 그 진피 발효 추출물이 개시되어 있으며, 한국등록특허 제0126380호에 체중감량용 조성물에 관해 개시되어 있으나 본 발명의 금강송 발효물을 유효성분으로 함유하는 비만의 예방, 개선 또는 치료용 조성물에 관한 기술은 개시된 바 없다. On the other hand, pine trees and pine needles have been known to have antimicrobial, sterilizing and deodorizing functions from the past, and Kumkansong, which is also called "Chungyangmok", is known to have excellent deodorizing action due to its unique wood structure. As a related art including pine needle as an active ingredient, Korean Patent Laid-Open Publication No. 2014-0036053 discloses a technique for improving metabolic syndrome improving functional rice cakes containing pine needle juice as an active ingredient, and Korean Patent No. 1326271 Discloses a method for producing a fermented dermis extract having an anti-obesity effect and a fermented fermented extract thereof. Korean Patent Registration No. 0126380 discloses a composition for weight loss, No description has been made on a composition for preventing, ameliorating or treating obesity.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방, 개선 및 치료용 조성물을 제공하고, 상기 유효성분인 금강송 발효물이 금강송 발효전 배양액에 비해 지방 축적을 억제한다는 것을 확인함으로써, 본 발명을 완성하였다.The present invention provides a composition for preventing, ameliorating and treating obesity comprising a fermented product of a goldsmith carrier as an active ingredient. The present invention provides a composition for prevention, improvement and treatment of obesity, The inventors of the present invention have completed the present invention.
상기 목적을 달성하기 위하여, 본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방 또는 개선용 건강기능식품 조성물을 제공한다.In order to achieve the above object, the present invention provides a health functional food composition for preventing or ameliorating obesity, comprising a fermented product as an active ingredient.
또한, 본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방 또는 치료용 약학 조성물을 제공한다.The present invention also provides a pharmaceutical composition for preventing or treating obesity, which comprises a fermented product as a active ingredient.
본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방, 개선 및 치료용 조성물에 관한 것으로, 상세하게는 금강송 발효물은 금강송 잎 또는 가지 분말을 1차 알코올 발효하고, 그 알코올 발효물을 2차 초산 발효한 것으로, 지방세포 축적을 억제하는 효과가 있는 것이다. 따라서, 본 발명의 금강송 발효물은 비만 관련 산업에 널리 사용될 수 있다.The present invention relates to a composition for prevention, improvement and treatment of obesity, which comprises a fermented product of a goldfish sprout as an active ingredient. More specifically, the fermented product of a goldfish sprout is a fermented product of primary fermentation It is fermented with ferric acetic acid and has an effect of inhibiting accumulation of adipocytes. Therefore, the gold-smelting fermented product of the present invention can be widely used in an obesity-related industry.
도 1은 본 발명의 금강송 발효물의 제조과정을 개략적으로 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른, 금강송 분말의 첨가량에 따른 알코올 발효물의 당도 및 알코올 함량의 차이를 확인한 결과이다.
도 3은 본 발명의 일 실시예에 따른, 금강송 배양액에 금강송 분말 이외에, 추가로, 설탕(A), 사과농축액(B) 및 현미(C)의 부원료 첨가함에 따른 알코올 발효물의 당도 및 알코올 함량의 차이를 확인한 결과이다.
도 4는 본 발명의 일 실시예에 따른, 금강송 배양액의 초기 당도(12~16 브릭스)에 따른 알코올 발효물의 당도의 변화 및 알코올 생성량을 확인한 결과이다.
도 5는 본 발명의 일 실시예에 따른, 금강송 배양액에 금강송 분말 이외에 추가로, 설탕(A), 사과농축액(B) 및 현미(C)의 부원료 첨가함에 따른 초산 발효물의 당도 변화 및 적정 산도(titratable acidity)의 변화를 확인한 결과이다.
도 6은 본 발명의 일 실시예에 따른, 초산 발효 전의 산도 차이(1~3%)에 따른 초산 발효물의 적정 산도(titratable acidity) 및 알코올 함량 변화를 확인한 결과이다.
도 7은 본 발명의 일 실시예에 따른, 금강송 발효물의 지방 축적 억제율을 확인한 결과이다.FIG. 1 schematically shows a manufacturing process of a gold-smelting fermentation product of the present invention.
FIG. 2 is a graph showing the difference in the sugar content and the alcohol content of the fermented alcohol according to the addition amount of the poultry meal powder according to an embodiment of the present invention.
FIG. 3 is a graph showing the degree of sugar content and alcohol content of an alcoholic fermented product according to addition of sugar (A), apple concentrate (B) and brown rice (C) This is the result of confirming the difference.
FIG. 4 is a graph showing changes in sugar content and alcohol production of alcohol fermented according to the initial sugar content (12 to 16 Bricks) of the culture media of Kumkang River according to an embodiment of the present invention.
FIG. 5 is a graph showing changes in sugar content and titratable acidity of acetic acid fermented product according to addition of sugar (A), apple concentrate (B) and brown rice (C) titratable acidity.
FIG. 6 shows the results of confirming titratable acidity and alcohol content changes of the acetic acid fermented product according to acidity difference (1 to 3%) before acetic acid fermentation according to an embodiment of the present invention.
FIG. 7 shows the result of confirming the rate of inhibition of fat accumulation in the fermented product of the poultry meat according to an embodiment of the present invention.
본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방 또는 개선용 건강기능식품 조성물에 관한 것이다.The present invention relates to a health functional food composition for preventing or ameliorating obesity, comprising a fermented product of a goldsmith carrier as an active ingredient.
상기 금강송 발효물은 금강송 잎 또는 가지의 분말을 발효한 것이 바람직하지만 이에 한정하지 않는다. 상기 금강송 발효물은 지방세포 축적을 억제하는 것이 특징이다. 상기 금강송 발효물은 (1) 금강송 분말을 포함하는 배양액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종하여 알코올 발효하고, (2) 상기 (1)에서 획득한 금강송 알코올 발효물에 아세토박터 속(Acetobacter sp.) 균주를 접종하여 초산 발효한 것이 바람직하지만 이에 한정하지 않으며, 상기 알코올 발효하는 균주 또는 초산 발효하는 균주는 얼마든지 선택하여 사용할 수 있는 것이다. 상기 금강송 발효액은 5~30중량%의 금강송 분말을 포함하는 것이 바람직하며, 더 바람직하게는 15중량%의 금강송 분말을 포함하는 것이지만, 이에 한정하는 것은 아니다. The fermented product of the present invention is preferably fermented by a fermented tea leaf or a powder of a branch, but is not limited thereto. The fermented product of the present invention is characterized by inhibiting accumulation of adipocytes. The fermented fish product of the present invention can be obtained by (1) culturing Saccharomyces cerevisiae cerevisiae , and (2) fermenting the fermented product obtained in (1) above to a fermented product of Acetobacter but it is not limited thereto. Any of the strains fermenting alcohol or fermenting acetic acid may be selected and used. Preferably, the fermentation liquid includes 5 to 30% by weight of the pneumoconiotic powder, and more preferably 15% by weight of the pneumoconiotic powder. However, the present invention is not limited thereto.
상기 금강송 배양액은 금강송 분말 이외에 설탕, 사과농축액 또는 현미를 더 포함할 수 있으며, 바람직하게는 사과농축액을 포함하는 것이지만 이에 한정하는 것은 아니다. The culture medium for suspension culture may further contain sugar, an apple concentrate or a brown rice in addition to the pest control powder, preferably an apple concentrate, but the present invention is not limited thereto.
상기 금강송 배양액은 초기 당도가 3~16 브릭스인 것이 바람직하며, 더 바람직하게는 12 브릭스인 것이지만 이에 한정하지 않으며, 상기 초산 발효의 초기 산도는 1~3%인 것이지만 이에 한정하는 것은 아니다. Preferably, the initial sugar content of the cultured poultry culture medium is 3 to 16 Bricks, more preferably 12 Bricks, but the present invention is not limited thereto. The initial acidity of the acetic acid fermentation is 1 to 3%, but is not limited thereto.
상기 알코올 발효 및 초산 발효는 28~32℃에서 3~5일 동안 수행하는 것이 바람직하며, 더 바람직하게는 30℃에서 4일 동안 알코올 발효 및 초산 발효하는 것이지만 이에 한정하는 것은 아니다. The alcohol fermentation and the acetic acid fermentation are preferably performed at 28 to 32 ° C. for 3 to 5 days, more preferably at 30 ° C. for 4 days for fermentation of alcohol and acetic acid.
본 발명의 금강송 발효물을 유효성분으로 함유하는 비만의 예방 또는 개선용 건강기능식품 조성물은 음료, 환, 정제(tablet), 캡슐제(capsule), 산제 중에서 선택된 어느 하나로 제조하거나, 다른 식품 또는 식품의 성분에 첨가하여 제조될 수 있으며, 통상적인 방법에 따라 적절하게 제조될 수 있다. The health functional food composition containing the fermented product of the present invention as an active ingredient for preventing or ameliorating obesity can be manufactured by any one selected from beverage, ring, tablet, capsule and powder, , And may be suitably prepared according to a conventional method.
본 발명의 건강기능식품 조성물을 첨가할 수 있는 식품의 일례로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 수프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 중에서 선택된 어느 하나의 형태일 수 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.Examples of foods to which the health functional food composition of the present invention can be added include meat products, sausages, breads, chocolate, candies, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, Beverage, tea, drink, alcoholic beverage, and vitamin complex, and includes all the health foods in the ordinary sense.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알킨산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional foods include various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, alkynic acid and its salts, , pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.
본 발명의 건강기능식품 조성물은 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐산과 같은 합성 감미제 등을 사용할 수 있다. The health functional food composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient. The natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, xylitol, sorbitol and erythritol. As the sweetening agent, natural sweetening agents such as tau Martin and stevia extract, synthetic sweetening agents such as saccharin and aspartic acid, and the like can be used.
또한, 본 발명은 금강송 발효물을 유효성분으로 포함하는 비만의 예방 또는 치료용 약학 조성물에 관한 것이다. 상기 금강송 발효물 이외에, 추가로 담체, 부형제 또는 희석제를 더 포함하는 것이 바람직하지만 이에 한정하는 것은 아니다. The present invention also relates to a pharmaceutical composition for preventing or treating obesity, which comprises a fermented product of a goldsmith carrier as an active ingredient. In addition to the above-mentioned fermentation product for a goldsmith, it is preferable to further include a carrier, an excipient or a diluent, but is not limited thereto.
본 발명의 약학 조성물은 경구 또는 비경구의 여러 가지 제형일 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형 제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형 제제는 하나 이상의 화합물에 적어도 하나 이상의 부형제 예를 들면, 전분, 탄산칼슘, 수크로오스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한, 단순한 부형제 이외에 스테아린산 마그네슘, 탈크 등과 같은 윤활제들도 사용된다. 경구 투여를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성 용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수성 용제 및 현탁 용제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈tween) 61, 카카오지, 라우린지, 글리세로 젤라틴 등이 사용될 수 있다.The pharmaceutical composition of the present invention may be various oral or parenteral formulations. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules, and the like, which may contain one or more excipients such as starch, calcium carbonate, sucrose or lactose lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate, talc, and the like may also be used. Liquid preparations for oral administration include suspensions, solutions, emulsions, syrups and the like. Various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included in addition to water and liquid paraffin, which are simple diluents commonly used. have. Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of non-aqueous solvents and suspensions include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, injectable esters such as ethyl oleate, and the like. Examples of suppositories include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
본 발명의 약학 조성물은 경구 또는 비경구로 투여될 수 있으며, 비경구 투여 시 피부 외용 또는 복강 내, 직장, 정맥, 근육, 피하, 자궁 내 경막 또는 뇌혈관 내 주사 방식을 선택하는 것이 바람직하며, 가장 바람직하게는 피부 외용으로 사용한다.The pharmaceutical composition of the present invention may be administered orally or parenterally, and it is preferable to select the intraperitoneal, rectal, rectal, intravenous, intramuscular, subcutaneous, intrauterine or intracerebral injection methods during parenteral administration, It is preferably used for external skin application.
본 발명에 따른 약학 조성물은 약제학적으로 유효한 양으로 투여한다. 본 발명에 있어서, "약제학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효용량 수준은 환자의 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명의 약학 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고 종래의 치료제와는 순차적 또는 동시에 투여될 수 있으며, 단일 또는 다중 투여될 수 있다. 상기한 요소들을 모두 고려하여 부작용없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 이는 당업자에 의해 용이하게 결정될 수 있다.The pharmaceutical composition according to the present invention is administered in a pharmaceutically effective amount. In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment, and the effective dose level will depend on the type of disease, severity, , Sensitivity to the drug, time of administration, route of administration and rate of release, duration of treatment, factors including co-administered drugs, and other factors well known in the medical arts. The pharmaceutical composition of the present invention can be administered as an individual therapeutic agent or in combination with other therapeutic agents, and can be administered sequentially or simultaneously with conventional therapeutic agents, and can be administered singly or in multiple doses. It is important to take into account all of the above factors and to administer the amount in which the maximum effect can be obtained in a minimal amount without side effects, which can be easily determined by those skilled in the art.
본 발명의 약학 조성물의 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설률 및 질환의 중증도에 따라 그 범위가 다양하게 사용할 수 있다.
The dosage of the pharmaceutical composition of the present invention may be varied depending on the patient's body weight, age, sex, health condition, diet, administration time, administration method, excretion rate, and severity of the disease.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.
[재료 및 방법][Materials and Methods]
1. 재료1. Materials
금강송 간벌 부산물(금강송 분말)은 '울진군 산림조합'에서 구매하여 사용하였으며, 사과농축액은 '엘림씨아이'에서 구매하여 원료로 사용하였다.The Kumkang shrimp by - product (Kumkwang powder) was purchased from Uljin Forestry Cooperative, and the apple concentrate was purchased from Elim Cai and used as raw material.
2. 사용 균주 및 배지 조성2. Use strain and medium composition
알코올 발효 균주는 사카로마이세스 세레비지애(Saccharomyces cerevisiae)를 YPD 평판 배지에 계대 배양 후, YPD 액체 배지에서 배양하였다. Alcohol fermentation strain Saccharomyces cerevisiae was subcultured in YPD plate medium and cultured in YPD liquid medium.
초산 발효 균주는 아세토박터 속(Acetobacter sp.) 균주를 사용하였으며, 배양 배지 조성은 하기 표 1에 나타내었다.Acetic acid fermentation strains were obtained from Acetobacter sp.), and the composition of the culture medium is shown in Table 1 below.
3. 금강송 간벌 부산물(금강송 분말)의 준비3. Preparation of Kumhwang Thrapen by-product (Kumhwang powder)
채취한 금강송 간벌 부산물(금강송 잎 및 가지)을 물에 침지하여 세척한 후, 물기를 잘 제거한 후, 파쇄기로 파쇄하여 분말화 한 후, 건조하고 발효에 사용하였다.
The collected ginseng shrimp by - products (leaves and branches) were washed and immersed in water. After the water was removed well, it was pulverized by crushing, pulverized, dried and used for fermentation.
4. 알코올 발효 조건4. Alcohol fermentation conditions
1) 금강송 간벌 부산물(금강송 분말)의 함량에 따른 알코올 발효1) Alcohol fermentation according to the content of Kumhang shim by-product
사과농축액(70°brix)을 정제수에 희석하여 당도 12°brix로 조절한 후, 5, 10, 15 및 30%(w/v)의 금강송 간벌 부산물(금강송 분말)을 첨가한 상기 발효액에 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종하여 30℃에서 96시간 동안 발효하였다.
The apple concentrate (70 ° brix) was diluted in purified water and adjusted to a sugar degree of 12 ° brix. The fermentation broth containing 5, 10, 15 and 30% (w / v) Saccharomyces S. cerevisiae were inoculated and fermented at 30 DEG C for 96 hours.
2) 부원료(설탕, 사과농축액 및 현미)의 종류에 따른 알코올 발효2) Alcohol fermentation according to kinds of additives (sugar, apple concentrate and brown rice)
알코올 발효 시, 설탕, 현미, 사과농축액을 첨가하고 초기 당도를 3~12 브릭스로 조절한 다음 96시간 동안 발효하였으며, 24시간 간격으로 당도와 알코올 함량을 측정하여 비교하였다.
When alcohol fermentation, sugar, brown rice, and apple concentrate were added and the initial sugar content was adjusted to 3 ~ 12 Bricks and fermented for 96 hours. The sugar content and alcohol content were measured at 24 hour intervals.
3) 초기 당도에 따른 알코올 발효3) Alcohol fermentation according to initial sugar content
초기 당도가 발효에 미치는 영향을 알아보기 위하여 발효액의 초기 당도를 12~16°brix 범위로 조절한 다음, 24시간 간격으로 당도 및 알코올 함량을 측정하였다.
The initial sugar content of the fermentation broth was adjusted to 12 ~ 16 ° brix and the sugar content and alcohol content were measured at 24 - hour intervals.
5. 초산 발효 조건5. Acetic acid fermentation conditions
1) 부원료(설탕, 사과농축액 및 현미)의 종류에 따른 초산 발효1) Acetic acid fermentation according to kinds of additives (sugar, apple concentrate and brown rice)
15%(w/v)의 금강송 간벌 부산물(금강송 분말)에 설탕, 사과농축액 및 현미를 첨가하여 알코올 발효한 알코올 발효액에 초산 균주인 아세토박터 속(Acetobacter sp.)을 접종하여 30℃에서 180rpm으로 72시간 배양하여 초산발효하였다.
To the fermentation broth of alcohol fermented by adding sugar, apple concentrate and brown rice to 15% (w / v) shrimp by - product (Kumunggwang powder), acetic acid bacteria Acetobacter sp.) and incubated at 30 캜 for 180 hours at 180 rpm for acetic acid fermentation.
2) 금강송 간벌 부산물(금강송 분말)의 최적 초산 발효 조건2) Optimum conditions of acetic acid fermentation of Kumhang shim by-product
금강송 간벌 부산물(금강송 분말)의 최적 초산 발효 조건을 탐색하기 위하여, 알코올 발효 종료액의 초기 산도를 1~3%로 조정하고 30℃에서 진탕배양(180rpm)을 하면서 24시간 간격으로 알코올 함량 변화 및 초산 함량 변화를 측정하였다.
In order to investigate the optimal acetic acid fermentation condition of Kumkang shrimp by - product (Kumkwang powder), the initial acidity of the end - of - fermentation solution was adjusted to 1 ~ 3% and the alcohol content was changed at 24 - Acetic acid content was measured.
실시예Example 1. 금강송 간벌 부산물(금강송 분말)의 함량에 따른 알코올 발효 조건 확립 1. Establishment of alcohol fermentation condition according to the contents of Kumhwang's thinning by-product
금강송 간벌 부산물(금강송 분말)을 알코올 발효하는 초기 조건으로, 12 브릭스의 사과농축액을 포함하는 발효액에, 5, 10, 15 및 30%(w/v)의 금강송 간벌 부산물(금강송 분말)을 첨가하고, 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주를 접종하여 30℃에서 96시간 동안 발효하였다.5, 10, 15 and 30% (w / v) gangshang thinning by-products (Kum-gang Song powder) were added to the fermentation broth containing 12 Bricks of apple concentrate as an initial condition for alcohol fermentation of Kum- , Celebi as Saccharomyces My jiae access (Saccharomyces S. cerevisiae were inoculated and fermented at 30 DEG C for 96 hours.
그 결과, 모든 실험군에서 시간이 지날수록 당도가 감소하고 알코올 함량이 증가하는 것으로 나타났다. 특히, 최종산물에서 15%(w/v)의 금강송 간벌 부산물(금강송 분말)을 첨가하였을 때, 알코올 함량이 가장 높게 나타났고, 30%(w/v)의 금강송 간벌 부산물(금강송 분말)을 첨가한 경우, 오히려 알코올 발효가 잘 일어나지 않아, 알코올의 함량이 가장 낮은 수준으로 확인되었다(도 2). 이와 같은 결과로부터 금강송 간벌 부산물(금강송 분말)의 농도가 너무 높아 발효가 잘 진행되지 않는다는 것을 알 수 있었다. As a result, the sugar content decreased and the alcohol content increased with time in all experimental groups. In particular, the alcohol content was highest when 15% (w / v) gangshang thinning by-product (Kumkwang powder) was added to the final product, and 30% (w / v) In one case, the alcohol fermentation did not occur well, and the alcohol content was found to be the lowest (Fig. 2). From these results, it can be concluded that the concentration of by - product of Kum - gum shrimp (Kum - shong powder) is too high and the fermentation does not progress well.
실시예Example 2. 부원료의 종류에 따른 알코올 발효 2. Alcohol fermentation according to kinds of additives
금강송 간벌 부산물(금강송 분말)의 알코올 발효 시, 발효에 도움을 주는 부원료가 알코올 발효에 미치는 영향을 확인하기 위하여, 15%(w/v)의 금강송 간벌 부산물(금강송 분말)에 설탕(12 브릭스), 사과농축액(12 브릭스) 또는 현미(3 브릭스)를 첨가하여 알코올 발효를 수행하였다.In order to investigate the effect of additives on the alcohol fermentation of alcoholic fermentation, we used sugar (12 bricks) in 15% (w / v) , Apple concentrate (12 bricks) or brown rice (3 bricks) were added to perform alcohol fermentation.
그 결과 모든 실험군에서 알코올 발효가 정상적으로 진행되는 것을 확인할 수 있었으며, 설탕, 사과농축액 또는 현미를 첨가한 알코올 발효 중에서 사과농축액을 첨가하였을 때 알코올 함유량이 가장 높은 것으로 확인되었다(도 3).
As a result, it was confirmed that alcohol fermentation proceeded normally in all experimental groups, and alcohol content was highest when alcohol concentrate was added in the alcohol fermentation with addition of sugar, apple concentrate or brown rice (FIG. 3).
실시예Example 3. 초기 당도에 따른 금강송 간벌 부산물(금강송 분말)의 알코올 발효 3. Alcohol fermentation of Ganghwangsun thinning by-product (Kumunggwang powder) according to initial sugar content
금강송 간벌 부산물(금강송 분말) 알코올 발효 시, 초기당도가 발효에 미치는 영향을 확인하기 위하여 15%(w/v)의 금강송 간벌 부산물(금강송 분말)에 12, 14, 16 브릭스(brix)의 사과농축액을 첨가하여 초기 당도를 조절한 후 발효를 수행하였다. In order to investigate the effect of initial sugar content on fermentation during alcohol fermentation, 15, 12, 14, and 16 brix apple concentrates were added to the shrimp by - product of 15% (w / v) And the fermentation was carried out after controlling the initial sugar content.
도 4에 개시한 바와 같이, 모든 군에서 알코올 발효는 정상적으로 진행되었으며, 초기 당도의 농도에 비례하여 알코올 함량이 증가하였으나 차이가 크지 않은 것으로 확인되었다. As shown in FIG. 4, alcohol fermentation proceeded normally in all groups, and the alcohol content was increased in proportion to the initial sugar content, but the difference was not significant.
따라서, 발효 효율성과 경제적인 면을 고려하였을 때 12 brix의 사과농축액으로 발효를 진행하는 것이 가장 적합한 것으로 판단하였다.
Therefore, considering fermentation efficiency and economical aspect, it was judged that fermentation with 12 brix apple concentrate is most suitable.
실시예Example 4. 부원료의 종류에 따른 금강송 간벌 부산물(금강송 분말)의 초산 발효 4. Acetic acid fermentation of Kumkang shim by-product (Kumkwang powder) according to the kind of additives
15%(w/v)의 금강송 간벌 부산물(금강송 분말)을 알코올 발효하여 획득한 알코올을 이용한 초산 발효 시, 발효에 도움을 주는 부원료가 초산 발효에 미치는 영향을 확인하기 위하여 간벌 부산물에 설탕, 사과농축액 또는 현미를 첨가하여 알코올 발효를 수행하였다.In order to investigate the effect of supplementary ingredients on the acetic acid fermentation during the acetic acid fermentation using alcohol obtained by alcohol fermentation of 15% (w / v) shrimp by - product (Kumunggwang powder) The concentrate or brown rice was added to conduct alcohol fermentation.
그 결과 모든 실험군에서 초산 발효가 정상적으로 진행되는 것을 확인할 수 있었으며, 상기 설탕, 사과농축액 또는 현미를 첨가한 경우, 알코올 발효 후, 초산 발효를 하는 경우, 사과농축액을 첨가하였을 때 초산의 함량이 가장 높은 것으로 확인되었다(도 5).
As a result, it was confirmed that the acetic acid fermentation proceeded normally in all the experimental groups. When the sugar, the apple concentrate or the brown rice was added, the acetic acid fermentation was performed after the alcohol fermentation, when the apple concentrate was added, (Fig. 5).
실시예Example 5. 초기 산도에 따른 금강송 간벌 부산물(금강송 분말)의 초산 발효 조건 확립 5. Establishment of Acetic Acid Fermentation Condition of Kumkang Stream Thumbnail By-product (Kumkang Song Powder) according to Initial Acidity
초기 산도가 금강송 간벌 부산물(금강송 분말)의 초산 발효에 미치는 영향을 알아보기 위하여 초기 산도를 1, 2 및 3%(v/v)로 조절하였다. Initial acidity was adjusted to 1, 2, and 3% (v / v) to investigate the effect of initial acidity on the acetic acid fermentation of Kumkangsong thinning by - product (Kumkwang powder).
그 결과 1%(v/v)에서 초산 발효가 가장 원활하게 진행되었으며, 2 및 3%(v/v)의 경우, 1%(v/v)에 비해 발효 속도가 느린 것을 확인할 수 있었다(도 6).
As a result, the acetic acid fermentation proceeded smoothly at 1% (v / v) and the fermentation rate was slower than 1% (v / v) at 2 and 3% (v / v) 6).
실시예Example 6. 금강송 간벌 부산물(금강송 분말)의 6. Ganghwangsun thinning by-product (Kumkwang powder) 발효물의Fermented 제조 Produce
상기 실시예 1~5의 결과를 바탕으로, 15%(w/v)의 금강송 분말 및 12 브릭스의 사과농축액을 첨가하여 4일간 알코올 발효를 수행한 후, 초기 산도를 1%로 조정하고, 초산발효를 수행하여, 가장 효과적으로 산도가 높아지는 것을 확인하였다.
On the basis of the results of Examples 1 to 5, 15% (w / v) Kumung Shipping Powder and 12 Bricks of apple concentrate were added to perform alcohol fermentation for 4 days, initial acidity was adjusted to 1% The fermentation was carried out to confirm that the acidity was the most effective.
실시예Example 7. 금강송 간벌 부산물(금강송 분말)을 포함하는 7. Including Ganghwanggang thinning by-product (Kumkangshan powder) 발효물의Fermented 항 비만 효능평가 Evaluation of anti-obesity efficacy
상기 실시예 6에서 획득한 금강송 발효물의 세포독성과 지방세포분화 억제율을 확인한 결과, 200㎍/㎖의 농도로 처리하였을 때 약 80% 이하의 세포 생존율을 나타냈고, 최종 발효물(초산 발효)을 100, 200 및 400㎍/㎖으로 처리했을 때, 지방세포 분화억제를 확인할 수 있었으며, 특히, 400㎍/㎖으로 처리했을 때, 약 23% 지방세포 분화 억제율을 나타냈다(도 7).The cytotoxicity and inhibitory rate of adipocyte differentiation of the fermented product obtained in Example 6 were found to be about 80% or less when treated at a concentration of 200 μg / ml, and the final fermentation product (acetic acid fermentation) 100, 200 and 400 / / ml, inhibition of adipocyte differentiation was observed. Especially, when treated at 400 / / ml, the inhibition rate of adipocyte differentiation was about 23% (Fig. 7).
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160075089A KR101829786B1 (en) | 2016-06-16 | 2016-06-16 | Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160075089A KR101829786B1 (en) | 2016-06-16 | 2016-06-16 | Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170141972A true KR20170141972A (en) | 2017-12-27 |
KR101829786B1 KR101829786B1 (en) | 2018-02-19 |
Family
ID=60938621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160075089A KR101829786B1 (en) | 2016-06-16 | 2016-06-16 | Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101829786B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102337130B1 (en) * | 2021-07-20 | 2021-12-10 | 유동민 | Composition comprising fermented Oriental medicine herbs for preventing, improving or treating obesity, and method for preparing the same |
-
2016
- 2016-06-16 KR KR1020160075089A patent/KR101829786B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102337130B1 (en) * | 2021-07-20 | 2021-12-10 | 유동민 | Composition comprising fermented Oriental medicine herbs for preventing, improving or treating obesity, and method for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
KR101829786B1 (en) | 2018-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150110378A (en) | Composition comprising extract post-fermented tea | |
KR20110041050A (en) | Composition containing extract of fermentated tea for improving circulation of blood and mitigating cold symptoms in hands and feet | |
KR102478724B1 (en) | A composition for diabetes or cardiovascular disease treatment comprising a citrus fermented kombucha | |
KR20100122296A (en) | Composition containing fermentation tea for improving blood circulation and pharmaceutical composition and health food composition comprising thereof | |
KR101559888B1 (en) | Composition for improving hepatoprotective activity comprising fermented garlic extracts | |
KR102275055B1 (en) | Composition comprising scutellaria alpina extract | |
KR102651296B1 (en) | Food composition containing kimchi for preventing or improving stomach cancer caused by Helicobacter pylori infection | |
KR101829786B1 (en) | Composition for preventing, improving or treating obesity comprising fermented Geomgangsong as effective component | |
KR102512998B1 (en) | New probiotics for reduction of body fat and use thereof | |
KR101509796B1 (en) | Composition for preventing or treating obesity comprising blueberry fermentation extract | |
KR102151011B1 (en) | Composition for preventing, improving or treating liver disease comprising fermented liquor of aged sprout ginseng extract as effective component | |
KR20230095471A (en) | Composition for improving muscle strength comprising fermented Schisandra chinensis fruit byproduct and method for preparing the same | |
KR101913940B1 (en) | Composition for preventing and treating vascular disorders | |
KR101843727B1 (en) | Composition for preventing, improving or treating obesity comprising Geomgangsong extract as effective component | |
KR20190053108A (en) | A composition comprising the complex extract for antiobesity of men | |
KR101302652B1 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS COMPRISING α-GLUCOSIDASE INHIBITOR AND BREWER'S DRIED YEAST | |
KR101760163B1 (en) | Composition for anti-obesity comprising extract of Sargassum serratifolium as an effective component | |
KR102128510B1 (en) | Composition comprising extract of Panax ginseng and Liriope platyphylla for preventing or treating learning, cognition or memory disabilities | |
KR20210074865A (en) | Pharmaceutical composition for preventing or treating diabetes, including extract of fermented tea leaves | |
KR102217834B1 (en) | Composition for Preventing or Treating Obesity Comprising Heat-killed Lactic Acid Bacteria from Kefir and Grape Seed Flour | |
KR102242002B1 (en) | Composition for preventing or treating fatty liver disease comprising solid phase fermented red ginseng extract by cordyceps | |
KR102616724B1 (en) | Composition for improving muscle strength comprising fermented Schisandra chinensis fruit byproduct and method for preparing the same | |
KR20190084732A (en) | A composition for improving, preventing and treating obesity comprising fermented pollack skin | |
KR101904819B1 (en) | Composition comprising Fermented Momordica charantia L. and Allium sativum L. using Amyloliquefaciens Bacillus Jis-1 for lowering blood glucose or preventing and treating diabetes mellitus | |
KR102290222B1 (en) | Composition for preventing or treating nonalcoholic fatty liver disease comprising extract of Rubus coreanus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |